118 related articles for article (PubMed ID: 38672808)
1. Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation.
Elsherbeny MH; Ammar UM; Abdellattif MH; Abourehab MAS; Abdeen A; Ibrahim SF; Abdelrahaman D; Mady W; Roh EJ; Elkamhawy A
Life (Basel); 2024 Mar; 14(4):. PubMed ID: 38672808
[TBL] [Abstract][Full Text] [Related]
2. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation.
Elsherbeny MH; Ammar UM; Abdellattif MH; Abourehab MAS; Abdeen A; Ibrahim SF; Abdelrahaman D; Mady W; Roh EJ; Elkamhawy A
Life (Basel); 2022 Jun; 12(6):. PubMed ID: 35743907
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of 6-(imidazo[1,2-a] pyridin-6-yl) quinazolin-4(3H)-one derivatives as potent anticancer agents by dual targeting Aurora kinase and ROR1.
Fan Y; Zhang F; Xiong L; Su M; Luo F; Li M; Li Q; Zhong T; Yuan M; Xu Y; Mu S; Yang H
Bioorg Chem; 2023 Jun; 135():106484. PubMed ID: 36963371
[TBL] [Abstract][Full Text] [Related]
4. Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases.
Shin SY; Yoon H; Hwang D; Ahn S; Kim DW; Koh D; Lee YH; Lim Y
Bioorg Med Chem; 2013 Nov; 21(22):7018-24. PubMed ID: 24095020
[TBL] [Abstract][Full Text] [Related]
5. Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors.
Long L; Wang YH; Zhuo JX; Tu ZC; Wu R; Yan M; Liu Q; Lu G
Eur J Med Chem; 2018 Sep; 157():1361-1375. PubMed ID: 30196060
[TBL] [Abstract][Full Text] [Related]
6. Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.
Jung Y; Shin SY; Yong Y; Jung H; Ahn S; Lee YH; Lim Y
Chem Biol Drug Des; 2015 May; 85(5):574-85. PubMed ID: 25298094
[TBL] [Abstract][Full Text] [Related]
7. A novel class of pyrazole analogues as aurora kinase A inhibitor: design, synthesis, and anticancer evaluation.
Yevale DB; Teraiya N; Lalwani TD; Ameta RK; Sangani CB
Bioorg Chem; 2023 Dec; 141():106901. PubMed ID: 37797455
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design.
Chang CF; Lin WH; Ke YY; Lin YS; Wang WC; Chen CH; Kuo PC; Hsu JTA; Uang BJ; Hsieh HP
Eur J Med Chem; 2016 Nov; 124():186-199. PubMed ID: 27573544
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of polyphenols with 4,6-diphenylpyrimidin-2-amine derivatives for inhibition of Aurora kinase A.
Lee YH; Park J; Ahn S; Lee Y; Lee J; Shin SY; Koh D; Lim Y
Daru; 2019 Jun; 27(1):265-281. PubMed ID: 31154600
[TBL] [Abstract][Full Text] [Related]
10. Development and biological evaluation of a novel aurora A kinase inhibitor.
Sardon T; Cottin T; Xu J; Giannis A; Vernos I
Chembiochem; 2009 Feb; 10(3):464-78. PubMed ID: 19199284
[TBL] [Abstract][Full Text] [Related]
11. Combined
Islam S; Teo T; Kumarasiri M; Slater M; Martin JH; Wang S; Head R
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297298
[TBL] [Abstract][Full Text] [Related]
12. Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights.
Al-Sanea MM; Elkamhawy A; Paik S; Lee K; El Kerdawy AM; Syed Nasir Abbas B; Joo Roh E; Eldehna WM; Elshemy HAH; Bakr RB; Ali Farahat I; Alzarea AI; Alzarea SI; Alharbi KS; Abdelgawad MA
Bioorg Med Chem; 2020 Jul; 28(13):115525. PubMed ID: 32371117
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biochemical Evaluation of New Triazole Derivatives as Aurora-A Kinase Inhibitors.
Abdullah O
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577149
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition.
Fan C; Zhong T; Yang H; Yang Y; Wang D; Yang X; Xu Y; Fan Y
Eur J Med Chem; 2020 Mar; 190():112108. PubMed ID: 32058239
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory Effect of Synthetic Flavone Derivatives on Pan-Aurora Kinases: Induction of G2/M Cell-Cycle Arrest and Apoptosis in HCT116 Human Colon Cancer Cells.
Shin SY; Lee Y; Kim BS; Lee J; Ahn S; Koh D; Lim Y; Lee YH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562979
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A/B kinase inhibitors.
Zheng Y; Zheng M; Ling X; Liu Y; Xue Y; An L; Gu N; Ji M
Bioorg Med Chem Lett; 2013 Jun; 23(12):3523-30. PubMed ID: 23664099
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of hinge-binder tethered 1,2,3-triazolylsalicylamide derivatives as Aurora kinase inhibitors.
Jeong Y; Lee J; Ryu JS
Bioorg Med Chem; 2016 May; 24(9):2114-24. PubMed ID: 27041399
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel 2,4-disubstituted pyrimidines as Aurora kinase inhibitors.
Xu Y; Hao SY; Zhang XJ; Li WB; Qiao XP; Wang ZX; Chen SW
Bioorg Med Chem Lett; 2020 Feb; 30(3):126885. PubMed ID: 31862411
[TBL] [Abstract][Full Text] [Related]
19. LRD-22, a novel dual dithiocarbamatic acid ester, inhibits Aurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cells.
Wang H; Li R; Li L; Ge Z; Zhou R; Li R
Biochem Biophys Res Commun; 2015 Feb; 458(1):201-7. PubMed ID: 25645017
[TBL] [Abstract][Full Text] [Related]
20. The synthesis and anti-tumour properties of novel 4-substituted phthalazinones as Aurora B kinase inhibitors.
Zhang XJ; Xu Y; Mou HX; Wang S; Hao SY; Chen SW
Bioorg Med Chem Lett; 2020 Dec; 30(23):127556. PubMed ID: 32941989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
